GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » Cyclically Adjusted FCF per Share

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Cyclically Adjusted FCF per Share : ¥-0.01 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shanxi Zhendong Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.093. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-0.01 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 63.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 47.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Shanxi Zhendong Pharmaceutical Co was 63.80% per year. The lowest was 35.40% per year. And the median was 44.20% per year.

As of today (2024-06-20), Shanxi Zhendong Pharmaceutical Co's current stock price is ¥3.92. Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥-0.01. Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is .


Shanxi Zhendong Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Shanxi Zhendong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.23 -0.21 -0.07 -0.04 -0.01

Shanxi Zhendong Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.01 -0.02 -0.01 -0.01

Competitive Comparison of Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Shanxi Zhendong Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanxi Zhendong Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.093/115.2271*115.2271
=-0.093

Current CPI (Mar. 2024) = 115.2271.

Shanxi Zhendong Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.095 98.200 -0.111
201409 -0.053 98.900 -0.062
201412 0.102 99.000 0.119
201503 -0.046 99.900 -0.053
201506 -0.016 99.500 -0.019
201509 -0.047 100.500 -0.054
201512 0.292 100.600 0.334
201603 -0.187 102.200 -0.211
201606 0.176 101.400 0.200
201609 -0.239 102.400 -0.269
201612 -0.026 102.600 -0.029
201703 -0.077 103.200 -0.086
201706 -0.100 103.100 -0.112
201709 -0.101 104.100 -0.112
201712 0.358 104.500 0.395
201803 -0.183 105.300 -0.200
201806 0.097 104.900 0.107
201809 0.014 106.600 0.015
201812 0.195 106.500 0.211
201903 0.005 107.700 0.005
201906 0.171 107.700 0.183
201909 0.005 109.800 0.005
201912 -0.019 111.200 -0.020
202003 -0.029 112.300 -0.030
202006 0.123 110.400 0.128
202009 -0.080 111.700 -0.083
202012 0.023 111.500 0.024
202103 -0.225 112.662 -0.230
202106 0.148 111.769 0.153
202109 0.215 112.215 0.221
202112 -0.009 113.108 -0.009
202203 0.064 114.335 0.064
202206 -0.134 114.558 -0.135
202209 -0.093 115.339 -0.093
202212 0.104 115.116 0.104
202303 -0.228 115.116 -0.228
202306 0.065 114.558 0.065
202309 -0.159 115.339 -0.159
202312 -0.059 114.781 -0.059
202403 -0.093 115.227 -0.093

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Shanxi Zhendong Pharmaceutical Co  (SZSE:300158) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shanxi Zhendong Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Shanxi Zhendong Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Business Description

Traded in Other Exchanges
N/A
Address
Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100
Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.
Executives
Miao Hui Director
Ma Shi Feng Executives
Li Zhi Xu Executives
Li Xi Hai Director
You Rong Li Executives
Wang Xu Wen Executives
Dong Mi Zhu Directors, executives
Li Ren Hu Supervisors
Ning Lu Hong Directors, executives
Wang Li Qing Supervisors
Jin Zhi Xiang Supervisors

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Headlines

No Headlines